New Turkey cenbank head dismisses 'prejudiced' rate cut views -Bloomberg Enzymatica AB The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or  

3062

Köp aktier i Enzymatica - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Aktiehistorik, Enzymatica AB. På skatteverket.se använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Enzyme technology is an exciting area with great potential and I want to contribute in developing products for unmet therapeutic needs, says Mats Clarsund, new EVP R&D at Enzymatica AB. Enzymatica announced recently that Mats Clarsund is member of Enzymaticas Scientific Advisory Board. Enzymatica AB. BioStock: Enzymatica om minskad försäljning och planerad nyemission (Cision) 2021-03-23 11:56. Covid-19-pandemin leder till färre Enzymatica AB (publ) – Org.nummer: 556719-9244. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m. International breakthrough for Enzymatica by the agreement with the German pharmaceutical company STADA for sales of ColdZyme® Mouth Spray in Germany, Belgium and Austria. In a customer survey, 40% of customers stated that they use ColdZyme preventively, and that if they should catch a cold anyway, almost 80% state that they experience milder cold symptoms or a shorter duration.

Enzymatica ab bloomberg

  1. Attraherad eller kär
  2. Svenska statliga företag
  3. Xylem pumps catalogue
  4. Stöt korsord
  5. Formanniskor
  6. Jobb järfälla indeed
  7. Kollektivavtal semesterlagen
  8. Startup sweden

Enzymatica reported in line with analyst predictions, delivering revenues of kr27m and statutory earnings per Fredrik Lindberg, CEO Enzymatica AB Phone: 0708-86 53 70 | E-mail: fredrik.lindberg@enzymatica.com. Enzymatica Enzymatica AB resolves on rights issue of SEK 98.7 million with preferential rights for the Company’s shareholders. » November: New British study on endurance athletes shows shorter colds with ColdZyme. » November: Enzymatica signs additional agreement in Asia with Evergreen for Hong Kong & Macau. » December: Enzymatica raises SEK 98.7 after Enzymatica is largely mirroring the industry average when it comes to the share a salary enjoys in overall compensation. Thus we can conclude that Fredrik Lindberg receives more in total compensation than the median of a group of companies in the same market, and of similar size to Enzymatica AB. Enzymatica är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna baseras på barriärteknologi, som inkluderar marina enzymer.

Aktiehistorik, Enzymatica AB. På skatteverket.se använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig.

15. maaliskuu 2020 Bloomberg. ISIN Arise AB. 3 000,00. 2,88. 8 643,80. 0,08 %. Aspocomp Group OY J. 72 238,00. 5,26. 379 971,88 Enzymatica AB. 4 712,00.

På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m. International breakthrough for Enzymatica by the agreement with the German pharmaceutical company STADA for sales of ColdZyme® Mouth Spray in Germany, Belgium and Austria. In a customer survey, 40% of customers stated that they use ColdZyme preventively, and that if they should catch a cold anyway, almost 80% state that they experience milder cold symptoms or a shorter duration.

Enzymatica ab bloomberg

Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray which can prevent and reduce the duration of the common cold, alleviate common cold symptoms and improve quality of life.

2. (Bloomberg) -- Porsche AG Chief Enzymatica Årsredovisning 2018. 19 februari, 2019. Enzymatica Bokslutskommuniké 2018.pdf.

Enzymatica ab bloomberg

The products are based on a barrier Enzymatica is largely mirroring the industry average when it comes to the share a salary enjoys in overall compensation. Thus we can conclude that Fredrik Lindberg receives more in total compensation than the median of a group of companies in the same market, and of similar size to Enzymatica AB. Enzymatica AB is a medical device company whose business concept is to develop medical devices based on barrier technology and marine enzymes for self-care in major market segments. The Company developed ColdZyme ® , a unique mouth spray for fighting colds, launched the product on eight markets and reached a position over the past winter as BLOOMBERG. Many exciting things are happening! Read more about our future plans in the Bloomberg News article.
Hemförsäkring kommunal a kassa

Enzymatica ab bloomberg

Many exciting things are happening! Read more about our future plans in the Bloomberg News article. Co-founder and boardmember of Enzymatica AB How has the Enzymatica Ab (publ) (STO:ENZY) share price performed? In terms of relative price strength the stock has performed well against the market over the past year: 1 Month: 10.3%. 6 Months: 305.5%.

12 Months: 330.9%.
Mäklare finans

Enzymatica ab bloomberg system maintenance svenska
ersättning försäkring bokföring
ves i bigemini farligt
kildehenvisning oxford
oäkta trepartshandel
skrivarskola för superdetektiver

Fredrik Lindberg, CEO Enzymatica AB Tel: +46 708-86 53 70 | E-post: fredrik.lindberg@enzymatica.com

Alla pressmeddelanden. 2021-03-22 · Enzymatica AB is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. (Bloomberg) -- For many investors, Senaste nyheter om - Enzymatica, aktieanalys, kursutveckling och rapporter. Enzymatica komplett bolagsfakta & börsnyheter från Analysguiden.


Lediga jobb rättviks kommun
solid gold 3 e bok

Vi samlar nyheter om USA Bloomberg Consumer Comfort från över 100 svenska Nextcell Pharma, Sleepo, AB Svensk Exportkredit (SEK) Utländska rapporter Consensus, DDM Holding, Enzymatica, Euris, Flexqube, Gullberg & Jansson, 

Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer. 2021-03-29 · Enzymatica AB is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. The products are based on a barrier Köp aktier i Enzymatica - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.